Nam-Gu Her

Company: Aimed Bio Inc.

Job title: Chief Executive Officer

Seminars:

1:30pm Innovative ADC Development: Preclinical Insights on Efficacy & Safety for an Emerging Target 1:30 pm

Identifying and developing competitive and underexplored emerging targets with tailored antibodies for ADCs Optimizing ADC platforms and selecting the most predictive preclinical models Evaluating safety profiles to determine clinical development value and patient benefitsRead more

day: Day One Preclinical & Clinical Development Track